Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Thymocyte responsiveness to endogenous glucocorticoids is required for immunological fitness
Paul R. Mittelstadt, … , João P. Monteiro, Jonathan D. Ashwell
Paul R. Mittelstadt, … , João P. Monteiro, Jonathan D. Ashwell
Published June 1, 2012
Citation Information: J Clin Invest. 2012;122(7):2384-2394. https://doi.org/10.1172/JCI63067.
View: Text | PDF
Research Article Immunology Article has an altmetric score of 5

Thymocyte responsiveness to endogenous glucocorticoids is required for immunological fitness

  • Text
  • PDF
Abstract

Generation of a self-tolerant but antigen-responsive T cell repertoire occurs in the thymus. Although glucocorticoids are usually considered immunosuppressive, there is also evidence that they play a positive role in thymocyte selection. To address the question of how endogenous glucocorticoids might influence the adaptive immune response, we generated GRlck-Cre mice, in which the glucocorticoid receptor gene (GR) is deleted in thymocytes prior to selection. These mice were immunocompromised, with reduced polyclonal T cell proliferative responses to alloantigen, defined peptide antigens, and viral infection. This was not due to an intrinsic proliferation defect, because GR-deficient T cells responded normally when the TCR was cross-linked with antibodies or when the T cell repertoire was “fixed” with αβ TCR transgenes. Varying the affinity of self ligands in αβ TCR transgenic mice showed that affinities that would normally lead to thymocyte-positive selection caused negative selection, and alterations in the TCR repertoire of polyclonal T cells were confirmed by analysis of TCR Vβ CDR3 regions. Thus, endogenous glucocorticoids are required for a robust adaptive immune response because of their promotion of the selection of T cells that have sufficient affinity for self, and the absence of thymocyte glucocorticoid signaling results in an immunocompromised state.

Authors

Paul R. Mittelstadt, João P. Monteiro, Jonathan D. Ashwell

×

Figure 1

Physical and functional characterization of GR deletion.

Options: View larger image (or click on image) Download as PowerPoint
Physical and functional characterization of GR deletion.
(A) Immunoblott...
(A) Immunoblotting was performed to determine GR levels in (left panel) purified WT, heterozygous, and GRlck-Cre CD4+ thymocytes; (middle panel) sorted WT and GRlck-Cre thymocytes; and (right panel) sorted DN3, DN4, and DP GRlck-Cre thymocytes (in the right panel, non-contiguous lanes from a single gel were rearranged as indicated by the white line). (B) GRlck-Cre T cells do not upregulate Gilz mRNA in response to Dex. Sorted T cells were treated or not with 100 nM Dex for 1.5 hours, and Gilz mRNA levels were quantitated by real-time PCR. (C) Glucocorticoids do not kill GRlck-Cre DP thymocytes. Thymocytes were incubated with the indicated concentrations of Dex overnight, then stained for CD4, CD8, and Annexin V as a marker of apoptosis, and the percent specific Annexin V positivity of CD4+CD8+ cells is shown. The data are representative of 3 independent experiments. (D) Glucocorticoids do not regulate IL-7Rα levels in GRlck-Cre T cells. Splenocytes were incubated overnight in the absence or presence of anti-CD3 in medium alone or with 100 nM Dex. Surface IL-7Rα expression on Thy-1+ cells is shown. The data are representative of 3 independent experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 5 X users
Referenced in 22 patents
94 readers on Mendeley
See more details